FISH del13q or LSI D13S319 Test for Multiple Myeloma
Comprehensive Genetic Analysis for Multiple Myeloma Diagnosis
The FISH del13q or LSI D13S319 Test represents a cutting-edge approach to Multiple Myeloma diagnosis and management. This specialized cytogenetic test utilizes fluorescence in situ hybridization (FISH) technology to detect critical genetic abnormalities in chromosome 13 that significantly impact disease prognosis and treatment strategies. As a leader in genetic diagnostics, GGC DNA provides this essential testing service to help patients and healthcare providers make informed decisions about Multiple Myeloma care.
What Does This Test Measure?
The FISH del13q or LSI D13S319 Test specifically targets and detects deletions in the 13q region of chromosome 13, particularly focusing on the D13S319 locus. This genetic region contains important tumor suppressor genes, and deletions in this area are strongly associated with:
- Detection of 13q14 chromosomal deletions
- Identification of specific genetic markers for Multiple Myeloma prognosis
- Assessment of disease aggressiveness and progression risk
- Evaluation of treatment response markers
Who Should Consider This Test?
This advanced genetic test is particularly important for individuals who:
- Have been diagnosed with Multiple Myeloma
- Are experiencing symptoms suggestive of plasma cell disorders
- Require prognostic stratification for treatment planning
- Need monitoring of disease progression or treatment response
- Have family history of hematological malignancies
Key Benefits of FISH del13q Testing
Choosing the FISH del13q or LSI D13S319 Test provides numerous advantages for patients and healthcare providers:
- Personalized Treatment Planning: Results guide targeted therapy selection based on genetic profile
- Prognostic Assessment: Helps determine disease aggressiveness and expected outcomes
- Early Detection: Identifies high-risk genetic features before clinical symptoms worsen
- Treatment Monitoring: Tracks genetic changes during therapy to assess effectiveness
- Comprehensive Care: Integrates with other diagnostic methods for complete disease evaluation
Understanding Your Test Results
Your FISH del13q or LSI D13S319 Test results will be carefully interpreted by our expert cytogeneticists:
- Normal Results: No deletion detected in the 13q region, indicating standard risk profile
- Abnormal Results: Detection of 13q deletion suggests higher-risk disease requiring more aggressive treatment
- Clinical Correlation: Results are interpreted in context with other clinical findings
- Follow-up Recommendations: Detailed guidance provided for next steps in management
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $150 |
| Regular Price | $212 |
Test Specifications
- Turnaround Time: Sample accepted daily by 4 pm; Reports delivered in 4 days
- Sample Type: 5 mL (3 mL minimum) whole blood OR 4 mL (2 mL minimum) Bone Marrow from 2 Green Top (Sodium Heparin) tubes
- Shipping Requirements: Ship at 18-22°C. DO NOT FREEZE
- Required Documentation: Duly filled Chromosome & FISH analysis Requisition Form (Form 17) is mandatory
Nationwide Accessibility
GGC DNA has branches across all major cities in the United States, ensuring convenient access to this essential genetic testing service. Our facilities in New York, Los Angeles, Chicago, Houston, and other metropolitan areas provide the same high-quality testing standards and expert interpretation.
Take Control of Your Health Today
Don’t wait to get the critical genetic information you need for optimal Multiple Myeloma management. Our team of experienced cytogeneticists and genetic counselors are ready to assist you with comprehensive testing and personalized result interpretation.
Book your FISH del13q or LSI D13S319 Test today by calling +1(267) 388-9828 or scheduling your appointment online. Take the first step toward personalized cancer care and informed treatment decisions.
